| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SLRN | ACELYRIN, Inc. | Lin Shao-Lee | Chief Executive Officer | Apr 01, 2024 | Sale | $6.63 | 9,961 | 66,024 | 1,577,374 | Apr 03, 2024, 06:18 PM | |
| SLRN | ACELYRIN, Inc. | Lin Shao-Lee | Chief Executive Officer | Feb 20, 2024 | Sale | $7.60 | 15,701 | 119,403 | 1,587,335 | Feb 22, 2024, 07:04 PM | |
| SLRN | ACELYRIN, Inc. | Lin Shao-Lee | Chief Executive Officer | Jan 02, 2024 | Sale | $7.41 | 10,691 | 79,188 | 1,603,036 | Jan 04, 2024, 06:09 PM | |
| SLRN | ACELYRIN, Inc. | Lin Shao-Lee | Chief Executive Officer | May 09, 2023 | Option Exercise | $24.69 | 337,179 | 8,324,950 | 770,034 | May 11, 2023, 08:50 PM | |
| HZNP | Horizon Therapeutics Public Ltd Co | Lin Shao-Lee | EVP, Head of R&D and CSO | Jan 21, 2020 | Option Exercise | $38.25 | 2,716 | 103,887 | 109,668 | Jan 23, 2020, 04:22 PM | |
| HZNP | Horizon Therapeutics Public Ltd Co | Lin Shao-Lee | EVP, Head of R&D and CSO | Jan 04, 2020 | Option Exercise | $36.10 | 8,113 | 292,879 | 58,359 | Jan 07, 2020, 06:21 PM | |
| HZNP | Horizon Therapeutics Public Ltd Co | Lin Shao-Lee | EVP, Head of R&D and CSO | Jan 05, 2020 | Option Exercise | $36.10 | 38,100 | 1,375,410 | 106,255 | Jan 07, 2020, 06:21 PM | |
| HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D and CSO | Feb 20, 2019 | Option Exercise | $21.54 | 15,795 | 340,224 | 47,531 | Feb 22, 2019, 05:23 PM | |
| HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D and CSO | Jan 04, 2019 | Option Exercise | $20.39 | 8,242 | 168,054 | 9,649 | Jan 08, 2019, 08:40 PM | |
| HZNP | Horizon Pharma plc | Lin Shao-Lee | EVP, Head of R&D and CSO | Jan 05, 2019 | Option Exercise | $20.39 | 14,337 | 292,331 | 27,674 | Jan 08, 2019, 08:40 PM |
Menu